ELEVIDYS
Generic: delandistrogene moxeparvovec-rokl
Manufacturer: Sarepta Therapeutics · Program: SareptAssist
Apply for assistanceFree to apply. Service from $40/month, payable only when your application is ready to submit.
Eligibility Criteria
Insurance Requirement
Available to US patients prescribed ELEVIDYS; helps with insurance navigation, prior authorizations, appeals; assistance for uninsured or underinsured
Residency
US resident
Financial assistance for eligible families with out-of-pocket costs, copays, and coinsurance; specific thresholds not detailed in sources
Program Information
Processing Time
2–4 weeks
Delivery Method
treatment center coordination
Application Method
Multiple
Indicated for
Duchenne muscular dystrophy (DMD)
About This Medication
SareptAssist Patient Guide: How to Get ELEVIDYS at Low or No Cost
ELEVIDYS (delandistrogene moxeparvovec-rokl) is a gene therapy for ambulatory patients 4 years and older with Duchenne muscular dystrophy (DMD) who have a confirmed DMD gene mutation. SareptAssist, from Sarepta Therapeutics, helps US patients access this treatment by navigating insurance, prior authorizations, appeals, and financial aid for out-of-pocket costs, copays, and coinsurance—especially for uninsured or underinsured families.[1][2][4]
About ELEVIDYS
ELEVIDYS is an FDA-approved one-time gene therapy infusion for eligible DMD patients. It delivers a functional version of the dystrophin gene to muscle cells via an AAV vector, aiming to slow disease progression. Administered at a specialized treatment center, it requires pre- and post-infusion systemic corticosteroids to manage risks like acute liver injury (boxed warning).[2]
Key facts:
- Indication: Ambulatory DMD patients ≥4 years with confirmed DMD mutation.
- Not recommended for those with certain conditions (e.g., severe liver issues).
- Post-infusion: Monitor liver function weekly for 3 months; stay near healthcare facilities for 2 months.[2]
Discuss with your doctor if ELEVIDYS fits your child's needs. SareptAssist coordinates logistics once prescribed.[1][3]
Who Qualifies for SareptAssist?
Available to US residents (including Puerto Rico) prescribed ELEVIDYS. No enrollment fee; a dedicated Case Manager provides personalized support.[1][4]
- Insured patients: Help with benefits investigation, prior authorizations (PAs), appeals, copay assistance.[1][3]
- Uninsured/underinsured: Free drug options via Patient Assistance Program (PAP), info on independent charities like Assistance Fund or Duchenne Family Assistance Program.[3][4][8]
- Needs-based for financial aid; eligibility assessed case-by-case.[4]
Income Eligibility Breakdown
Specific FPL thresholds aren't publicly detailed—eligibility is individualized based on insurance, household income, and circumstances. Contact SareptAssist for assessment.[1][4]
| Household Size | Threshold Example (if 400% FPL, illustrative)* | Notes |
|---|---|---|
| Individual | ~$60,000 | Assessed individually; copay aid for commercial insurance. |
| Couple | ~$81,000 | Uninsured may qualify for free drug. |
| Family of 3 | ~$102,000 | Third-party funds for premiums/travel. |
| Family of 4 | ~$123,000 | *Illustrative; call for exact eligibility.[1][3][8] |
*Note: These are estimates; SareptAssist confirms via application. Programs like copay assistance often cap aid at certain incomes but vary.[5][8]
Insurance Requirements
Commercial insurance: Case Manager verifies benefits, handles PAs/appeals, offers copay program (if eligible).[1][3] Medicare/Medicaid: Limited details; may direct to third-party aid. Not all federal programs covered—check with Case Manager.[4][8] Uninsured: PAP provides free ELEVIDYS if criteria met (FDA-approved diagnosis, US resident).[4]
SareptAssist shares insurer communications and follows up.[3]
Step-by-Step Application Process
- Get Prescribed: Doctor confirms eligibility and completes Sarepta Gene Therapy Enrollment Form.[3][6]
- Submit Form: Fax to 1-800-621-5203 or email SareptAssist@Sarepta.com.[4][6]
- Case Manager Contact: They'll call (1-888-727-3782, Mon-Fri 8:30am-6:30pm ET) to welcome you, explain benefits, and outline aid.[1][3]
- Benefits Investigation: Review insurance coverage/next steps.[1]
- Financial Assessment: Discuss copay/PAP/charity options; complete consent if eligible.[1][4]
- Approval & Coordination: Coordinate treatment center, logistics, pre-infusion labs.[1][3]
Spanish/other language support available.[1]
Timeline and Delivery
Processing varies (not specified; days to weeks based on insurance/PA). Case Manager updates you.[3]
- Delivery: Infused at a treatment center (not home); Case Manager facilitates.[1][3]
- Post-Treatment: Reminders for follow-ups, labs (liver monitoring 3 months).[2][3]
Stay proactive: Share insurer letters, attend appointments.[3]
Alternatives if Denied
- Appeal: Case Manager assists with insurer appeals.[1][3]
- Third-Party Aid: Assistance Fund (DMD fund for copays/premiums/travel), Duchenne Family Assistance.[3][8]
- Patient Advocacy: Parent Project Muscular Dystrophy (PPMD) resources.[9]
- Other Sarepta Therapies: If applicable (e.g., Exondys 51 for different mutations).[4]
No biosimilars for ELEVIDYS (unique gene therapy).[ ]
Disclaimer
This guide is for informational purposes; not medical/financial advice. Eligibility/funding can change—contact SareptAssist (1-888-727-3782) or your doctor for personalized info. ELEVIDYS has serious risks (e.g., liver failure); review full Prescribing Information. Programs subject to terms; manufacturer not liable for third-party aid.[1][2]
Word count: ~950
Program information last verified: March 30, 2026
Ready to apply for ELEVIDYS assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.
Need help finding a program?